NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 1 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,000 | +140.0% | 12,775 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 12,775 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -71.4% | 12,775 | -50.0% | 0.00% | – |
| Q4 2019 | $14,000 | +75.0% | 25,550 | +100.0% | 0.00% | – |
| Q3 2019 | $8,000 | -33.3% | 12,775 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -74.5% | 12,775 | +9.1% | 0.00% | – |
| Q1 2019 | $47,000 | +30.6% | 11,712 | -50.0% | 0.00% | – |
| Q4 2018 | $36,000 | -33.3% | 23,424 | +100.0% | 0.00% | – |
| Q3 2018 | $54,000 | – | 11,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 80,069 | $1,233,000 | 0.56% |